These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 264230)
1. Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease. Lloyd KG Prim Care; 1977 Sep; 4(3):561-75. PubMed ID: 264230 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy. Botez MI; Barbeau A Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311 [No Abstract] [Full Text] [Related]
3. [Secondary effects of prolonged levodopa therapy in Parkinson's disease]. Peiró Grasa A; Grau-Veciana JM Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630 [No Abstract] [Full Text] [Related]
12. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
13. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Sage JI; Mark MH Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688 [TBL] [Abstract][Full Text] [Related]
14. Levodopa in the treatment of Parkinson's disease. Lloyd KG Prim Care; 1977 Sep; 4(3):541-60. PubMed ID: 264229 [TBL] [Abstract][Full Text] [Related]
15. Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease. Bowers MB J Neuropsychiatry Clin Neurosci; 1996; 8(4):450-2. PubMed ID: 9116484 [TBL] [Abstract][Full Text] [Related]
16. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy. Fischer PA J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073 [TBL] [Abstract][Full Text] [Related]
17. The evolution and origin of motor complications in Parkinson's disease. Obeso JA; Rodriguez-Oroz MC; Chana P; Lera G; Rodriguez M; Olanow CW Neurology; 2000; 55(11 Suppl 4):S13-20; discussion S21-3. PubMed ID: 11147505 [TBL] [Abstract][Full Text] [Related]
18. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Zanetti R; Loria D; Rosso S Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266 [TBL] [Abstract][Full Text] [Related]
19. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy. Stern MB; Vernon GM; Gollomp SM; Hurtig HI Bull Clin Neurosci; 1986; 51():52-6. PubMed ID: 3455244 [TBL] [Abstract][Full Text] [Related]
20. [Motor complications in patients with Parkinson disease treated with levodopa]. Luquin MR; Obeso JA; Martínez-Lage JM Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]